The board of directors of Yonghe Medical Group Co., Ltd. provided earnings guidance based on a preliminary assessment of the Group's unaudited consolidated management accounts for the year ended 31 December 2023 and the information currently available to the Board, the Group expects to record a revenue of approximately RMB 1,765.0 million to RMB 1,780.0 million for the Year, representing an increase of approximately 24.9% to 26.0% over the revenue for the year ended 31 December 2022. Also, the Group expects to incur a loss of not more than RMB 550.0 million for the Year, as compared with a loss of RMB 85.9 million for the year ended December 31, 2022.